Molecular diagnostics in embryonal brain tumors
- PMID: 21129063
- PMCID: PMC3575597
- DOI: 10.1111/j.1750-3639.2010.00455.x
Molecular diagnostics in embryonal brain tumors
Abstract
Embryonal brain tumors are a heterogeneous group of neoplasms united by the presence of poorly differentiated stem-like cells. Molecular details are increasingly being used to separate them into biologically and clinically meaningful groups. For medulloblastoma, integrated mRNA expression profiling and DNA analysis by a number of research groups defines 4-6 distinctive molecular variants. A subset with prominent Wnt activity is associated with good clinical outcomes and classic histology. Medulloblastomas showing a Hedgehog gene expression signature are frequently of the desmoplastic/nodular subtype. Interestingly, Hedgehog activity is found in tumors arising either in infants or older teenagers and adults. The association of clinically aggressive medulloblastoma with MYC expression, large cell/anaplastic change and high levels of photoreceptor differentiation transcripts has also been noted in several studies. Immunohistochemical analysis of just one or two genes per molecular medulloblastoma variant may be sufficient for accurate classification, and this would be of great practical utility if validated. Advances have also been made in the classification of central nervous system (CNS) Primitive Neuroectodermal Tumors (PNET), as several groups have identified an amplicon at chromosome 19q13.41-42, which appears to define a unique PNET subtype associated with prominent true rosettes, young age and very poor outcomes.
© 2010 The Author; Brain Pathology © 2010 International Society of Neuropathology.
Figures


Similar articles
-
Molecular diagnostics of CNS embryonal tumors.Acta Neuropathol. 2010 Nov;120(5):553-66. doi: 10.1007/s00401-010-0751-5. Epub 2010 Sep 30. Acta Neuropathol. 2010. PMID: 20882288 Free PMC article. Review.
-
Embryonal tumors in the WHO CNS5 classification: A Review.Indian J Pathol Microbiol. 2022 May;65(Supplement):S73-S82. doi: 10.4103/ijpm.ijpm_1049_21. Indian J Pathol Microbiol. 2022. PMID: 35562137 Review.
-
Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.Cancer Res. 2019 Mar 1;79(5):905-917. doi: 10.1158/0008-5472.CAN-18-1261. Epub 2019 Jan 23. Cancer Res. 2019. PMID: 30674530 Free PMC article.
-
Primitive Neuroectodermal Tumor.2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32965836 Free Books & Documents.
-
Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.J Neurosurg. 2000 Sep;93(3):437-48. doi: 10.3171/jns.2000.93.3.0437. J Neurosurg. 2000. PMID: 10969942
Cited by
-
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct.Acta Neuropathol. 2011 Aug;122(2):231-40. doi: 10.1007/s00401-011-0846-7. Epub 2011 Jun 17. Acta Neuropathol. 2011. PMID: 21681522 Free PMC article.
-
A developmental program drives aggressive embryonal brain tumors.Nat Genet. 2014 Jan;46(1):2-3. doi: 10.1038/ng.2857. Nat Genet. 2014. PMID: 24370739
-
Effect of small nuclear ribonucleoprotein-associated polypeptide N on the proliferation of medulloblastoma cells.Mol Med Rep. 2015 May;11(5):3337-43. doi: 10.3892/mmr.2015.3148. Epub 2015 Jan 7. Mol Med Rep. 2015. PMID: 25571951 Free PMC article.
-
Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?Childs Nerv Syst. 2018 Sep;34(9):1657-1662. doi: 10.1007/s00381-018-3842-6. Epub 2018 Jun 4. Childs Nerv Syst. 2018. PMID: 29868932
-
Infratentorial medulloepithelioma with divergent differentiation: Possibly a predictor of poor outcome.J Pediatr Neurosci. 2012 May;7(2):142-5. doi: 10.4103/1817-1745.102581. J Pediatr Neurosci. 2012. PMID: 23248698 Free PMC article.
References
-
- Aldosari N, Bigner SH, Burger PC, Becker L, Kepner JL, Friedman HS, McLendon RE (2002) MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med 126:540–544. - PubMed
-
- Badiali M, Pession A, Basso G, Andreini L, Rigobello L, Galassi E, Giangaspero F (1991) N‐myc and c‐myc oncogenes amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c‐myc amplification. Tumori 77:118–121. - PubMed
-
- Baeza N, Masuoka J, Kleihues P, Ohgaki H (2003) AXIN1 mutations but not deletions in cerebellar medulloblastomas. Oncogene 22:632–636. - PubMed
-
- Batra SK, McLendon RE, Koo JS, Castelino‐Prabhu S, Fuchs HE, Krischer JP et al (1995) Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 24:39–45. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical